InfuSystem Holdings, Inc. Logo

InfuSystem Holdings, Inc.

INFU

(2.0)
Stock Price

8,31 USD

0.37% ROA

2.78% ROE

407.36x PER

Market Cap.

149.207.800,00 USD

63.88% DER

0% Yield

1.12% NPM

InfuSystem Holdings, Inc. Stock Analysis

InfuSystem Holdings, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

InfuSystem Holdings, Inc. Fundamental Stock Analysis
# Analysis Rating
1 Revenue Growth

This company's revenue has experienced steady growth over the last five years, indicating a reliable and prosperous financial trajectory.

2 Assets Growth

With a track record of consistent revenue growth in the past five years, this company presents a compelling opportunity.

3 ROE

The stock's ROE falls within an average range (1.36%), demonstrating satisfactory profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (0.73%) indicates that it's doing well in making money from the things it owns. This makes it a good option to invest and make consistent profits.

5 DER

The stock has a reasonable amount of debt compared to its ownership (80%), suggesting a balanced financial position and a moderate level of risk.

6 Buffet Intrinsic Value

Based on Warren Buffett's formula, the company's stock appears undervalued (140.826), presenting an attractive investment chance with its intrinsic value surpassing the current market price.

7 PBV

The stock's elevated P/BV ratio (3.9x) raises concerns about its overvaluation, making it an imprudent choice for investors seeking value.

8 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

9 Graham Number

Based on the Graham number, this company's stock price appears to be higher than its intrinsic value, signaling a potentially unfavorable investment choice.

10 Dividend Growth

The company's dividend growth has been flat for the past three years, raising concerns for potential investors seeking reliable returns.

11 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

InfuSystem Holdings, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

InfuSystem Holdings, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

InfuSystem Holdings, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

InfuSystem Holdings, Inc. Revenue
Year Revenue Growth
2005 0
2006 0 0%
2007 6.582.000 100%
2008 35.415.000 81.41%
2009 38.964.000 9.11%
2010 47.229.000 17.5%
2011 54.637.000 13.56%
2012 58.828.000 7.12%
2013 62.280.000 5.54%
2014 66.487.000 6.33%
2015 72.125.000 7.82%
2016 70.497.000 -2.31%
2017 71.077.000 0.82%
2018 67.138.000 -5.87%
2019 81.115.000 17.23%
2020 97.388.000 16.71%
2021 102.382.000 4.88%
2022 109.914.000 6.85%
2023 127.636.000 13.88%
2023 125.785.000 -1.47%
2024 134.792.000 6.68%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

InfuSystem Holdings, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

InfuSystem Holdings, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 919.218.000.000 100%
2007 4.891.000 -18793970.74%
2008 11.765.000 58.43%
2009 12.218.000 3.71%
2010 20.622.000 40.75%
2011 17.987.000 -14.65%
2012 23.062.000 22.01%
2013 18.973.000 -21.55%
2014 19.988.000 5.08%
2015 23.778.000 15.94%
2016 24.629.000 3.46%
2017 25.200.000 2.27%
2018 24.847.000 -1.42%
2019 29.023.000 14.39%
2020 35.195.000 17.54%
2021 42.261.000 16.72%
2022 46.077.000 8.28%
2023 46.968.000 1.9%
2023 45.377.000 -3.51%
2024 46.096.000 1.56%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

InfuSystem Holdings, Inc. EBITDA
Year EBITDA Growth
2005 -24.483
2006 -24.964.166 99.9%
2007 2.659.000 1038.86%
2008 11.226.000 76.31%
2009 11.776.000 4.67%
2010 7.658.000 -53.77%
2011 10.284.000 25.53%
2012 10.261.000 -0.22%
2013 14.230.000 27.89%
2014 15.486.000 8.11%
2015 17.120.000 9.54%
2016 11.724.000 -46.03%
2017 9.591.000 -22.24%
2018 11.686.000 17.93%
2019 15.770.000 25.9%
2020 22.823.000 30.9%
2021 17.259.000 -32.24%
2022 14.892.000 -15.89%
2023 19.004.000 21.64%
2023 16.596.000 -14.51%
2024 19.552.000 15.12%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

InfuSystem Holdings, Inc. Gross Profit
Year Gross Profit Growth
2005 0
2006 0 0%
2007 4.962.000 100%
2008 26.224.000 81.08%
2009 28.637.000 8.43%
2010 33.545.000 14.63%
2011 35.355.000 5.12%
2012 42.911.000 17.61%
2013 43.679.000 1.76%
2014 47.354.000 7.76%
2015 51.184.000 7.48%
2016 44.740.000 -14.4%
2017 43.361.000 -3.18%
2018 39.018.000 -11.13%
2019 46.882.000 16.77%
2020 58.759.000 20.21%
2021 60.197.000 2.39%
2022 62.571.000 3.79%
2023 64.984.000 3.71%
2023 61.019.000 -6.5%
2024 64.484.000 5.37%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

InfuSystem Holdings, Inc. Net Profit
Year Net Profit Growth
2005 -24.783
2006 -7.859.344 99.68%
2007 -2.796.000 -181.09%
2008 9.959.000 128.08%
2009 774.000 -1186.69%
2010 -1.852.000 141.79%
2011 -45.443.000 95.92%
2012 -1.489.000 -2951.91%
2013 1.669.000 189.22%
2014 3.357.000 50.28%
2015 3.743.000 10.31%
2016 -222.000 1786.04%
2017 -20.707.000 98.93%
2018 -1.095.000 -1791.05%
2019 1.361.000 180.46%
2020 17.332.000 92.15%
2021 1.420.000 -1120.56%
2022 18.000 -7788.89%
2023 2.756.000 99.35%
2023 872.000 -216.06%
2024 2.868.000 69.6%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

InfuSystem Holdings, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 -1 0%
2007 0 0%
2008 1 0%
2009 0 0%
2010 0 0%
2011 -2 100%
2012 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 -1 0%
2018 0 0%
2019 0 0%
2020 1 0%
2021 0 0%
2022 0 0%
2023 0 0%
2023 0 0%
2024 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

InfuSystem Holdings, Inc. Free Cashflow
Year Free Cashflow Growth
2005 -76
2006 -912.353 99.99%
2007 3.824.000 123.86%
2008 9.164.000 58.27%
2009 5.096.000 -79.83%
2010 8.368.000 39.1%
2011 1.619.000 -416.86%
2012 -1.090.000 248.53%
2013 1.501.000 172.62%
2014 -2.450.000 161.27%
2015 -3.191.000 23.22%
2016 -886.000 -260.16%
2017 3.988.000 122.22%
2018 3.088.000 -29.15%
2019 -8.720.000 135.41%
2020 3.366.000 359.06%
2021 1.660.000 -102.77%
2022 2.441.000 32%
2023 2.633.000 7.29%
2023 9.970.000 73.59%
2024 1.972.000 -405.58%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

InfuSystem Holdings, Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 -76
2006 -912.353 99.99%
2007 4.377.000 120.84%
2008 10.897.000 59.83%
2009 9.708.000 -12.25%
2010 10.812.000 10.21%
2011 7.172.000 -50.75%
2012 5.452.000 -31.55%
2013 7.463.000 26.95%
2014 7.255.000 -2.87%
2015 7.054.000 -2.85%
2016 7.909.000 10.81%
2017 7.583.000 -4.3%
2018 11.391.000 33.43%
2019 13.875.000 17.9%
2020 20.280.000 31.58%
2021 18.316.000 -10.72%
2022 17.517.000 -4.56%
2023 4.264.000 -310.81%
2023 10.994.000 61.22%
2024 2.309.000 -376.14%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

InfuSystem Holdings, Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 0 0%
2007 553.000 100%
2008 1.733.000 68.09%
2009 4.612.000 62.42%
2010 2.444.000 -88.71%
2011 5.553.000 55.99%
2012 6.542.000 15.12%
2013 5.962.000 -9.73%
2014 9.705.000 38.57%
2015 10.245.000 5.27%
2016 8.795.000 -16.49%
2017 3.595.000 -144.65%
2018 8.303.000 56.7%
2019 22.595.000 63.25%
2020 16.914.000 -33.59%
2021 16.656.000 -1.55%
2022 15.076.000 -10.48%
2023 1.631.000 -824.34%
2023 1.024.000 -59.28%
2024 337.000 -203.86%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

InfuSystem Holdings, Inc. Equity
Year Equity Growth
2005 -376
2006 65.145.780 100%
2007 68.759.000 5.25%
2008 80.073.000 14.13%
2009 81.465.000 1.71%
2010 85.143.000 4.32%
2011 40.165.000 -111.98%
2012 40.013.000 -0.38%
2013 42.723.000 6.34%
2014 46.452.000 8.03%
2015 51.278.000 9.41%
2016 50.689.000 -1.16%
2017 30.953.000 -63.76%
2018 20.441.000 -51.43%
2019 22.334.000 8.48%
2020 40.752.000 45.2%
2021 48.272.000 15.58%
2022 48.003.000 -0.56%
2023 51.469.000 6.73%
2023 52.302.000 1.59%
2024 53.487.000 2.22%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

InfuSystem Holdings, Inc. Assets
Year Assets Growth
2005 178.678
2006 100.297.830 99.82%
2007 116.426.000 13.85%
2008 116.220.000 -0.18%
2009 114.690.000 -1.33%
2010 130.364.000 12.02%
2011 76.263.000 -70.94%
2012 77.523.000 1.63%
2013 77.373.000 -0.19%
2014 80.213.000 3.54%
2015 96.449.000 16.83%
2016 96.344.000 -0.11%
2017 68.881.000 -39.87%
2018 64.073.000 -7.5%
2019 79.224.000 19.12%
2020 96.991.000 18.32%
2021 97.586.000 0.61%
2022 99.388.000 1.81%
2023 102.071.000 2.63%
2023 109.885.000 7.11%
2024 108.527.000 -1.25%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

InfuSystem Holdings, Inc. Liabilities
Year Liabilities Growth
2005 179.054
2006 35.152.050 99.49%
2007 47.667.000 26.25%
2008 36.147.000 -31.87%
2009 33.225.000 -8.79%
2010 45.221.000 26.53%
2011 36.098.000 -25.27%
2012 37.510.000 3.76%
2013 34.650.000 -8.25%
2014 33.761.000 -2.63%
2015 45.171.000 25.26%
2016 45.655.000 1.06%
2017 37.928.000 -20.37%
2018 43.632.000 13.07%
2019 56.890.000 23.3%
2020 56.239.000 -1.16%
2021 49.314.000 -14.04%
2022 51.385.000 4.03%
2023 50.602.000 -1.55%
2023 57.583.000 12.12%
2024 55.040.000 -4.62%

InfuSystem Holdings, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
6.07
Net Income per Share
0.02
Price to Earning Ratio
407.36x
Price To Sales Ratio
1.15x
POCF Ratio
13.1
PFCF Ratio
16.92
Price to Book Ratio
2.79
EV to Sales
1.45
EV Over EBITDA
11.7
EV to Operating CashFlow
16.54
EV to FreeCashFlow
21.34
Earnings Yield
0
FreeCashFlow Yield
0.06
Market Cap
0,15 Bil.
Enterprise Value
0,19 Bil.
Graham Number
0.99
Graham NetNet
-1.67

Income Statement Metrics

Net Income per Share
0.02
Income Quality
31.09
ROE
0.01
Return On Assets
0.01
Return On Capital Employed
0.06
Net Income per EBT
0.42
EBT Per Ebit
0.64
Ebit per Revenue
0.04
Effective Tax Rate
-0.21

Margins

Sales, General, & Administrative to Revenue
0.36
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0.03
Gross Profit Margin
0.5
Operating Profit Margin
0.04
Pretax Profit Margin
0.03
Net Profit Margin
0.01

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0.53
Free CashFlow per Share
0.41
Capex to Operating CashFlow
0.22
Capex to Revenue
0.02
Capex to Depreciation
0.21
Return on Invested Capital
0.01
Return on Tangible Assets
0
Days Sales Outstanding
60.16
Days Payables Outstanding
55.46
Days of Inventory on Hand
38.16
Receivables Turnover
6.07
Payables Turnover
6.58
Inventory Turnover
9.57
Capex per Share
0.12

Balance Sheet

Cash per Share
0,01
Book Value per Share
2,51
Tangible Book Value per Share
2.01
Shareholders Equity per Share
2.51
Interest Debt per Share
1.7
Debt to Equity
0.64
Debt to Assets
0.31
Net Debt to EBITDA
2.43
Current Ratio
2.07
Tangible Asset Value
0,04 Bil.
Net Current Asset Value
-0,02 Bil.
Invested Capital
37712999
Working Capital
0,02 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,02 Bil.
Average Payables
0,01 Bil.
Average Inventory
6544000
Debt to Market Cap
0.23

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

InfuSystem Holdings, Inc. Dividends
Year Dividends Growth

InfuSystem Holdings, Inc. Profile

About InfuSystem Holdings, Inc.

InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other alternate site settings comprising home care and home infusion providers, skilled nursing facilities, pain centers, hospital market, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan.

CEO
Mr. Richard A. DiIorio
Employee
499
Address
3851 West Hamlin Road
Rochester Hills, 48309

InfuSystem Holdings, Inc. Executives & BODs

InfuSystem Holdings, Inc. Executives & BODs
# Name Age
1 Mr. Jerod Funke
Executive Vice President & Chief HR Officer
70
2 Mr. Richard A. DiIorio
Chief Executive Officer & Director
70
3 Ms. Carrie A. Lachance B.S.N., M.B.A., R.N.
President, Chief Operating Officer & Director
70
4 Mr. Barry G. Steele CPA
Executive Vice President & Chief Financial Officer
70
5 Ms. Jeanie Latz
Corporate Secretary
70
6 Mr. Addam Chupa
Executive Vice President & Chief Information Officer
70

InfuSystem Holdings, Inc. Competitors